GRAL Quote, Financials, Valuation and Earnings

Hypha Labs, Inc. has a net margin of -227.48% compared to GRAIL, Inc.'s net margin of --. GRAIL, Inc.'s return on equity of -16.95% beat Hypha Labs, Inc.'s return on equity of --.

GRAIL, Inc. has a consensus price target of $88.00, signalling upside risk potential of 66.79%. On the other hand Hypha Labs, Inc. has an analysts' consensus of -- which suggests that it could fall by --. Given that GRAIL, Inc. has higher upside potential than Hypha Labs, Inc., analysts believe GRAIL, Inc. is more attractive than Hypha Labs, Inc..

GRAIL, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Hypha Labs, Inc. has a beta of 1.235, suggesting its more volatile than the S&P 500 by 23.534%.

GRAIL, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Hypha Labs, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. GRAIL, Inc. pays -- of its earnings as a dividend. Hypha Labs, Inc. pays out -- of its earnings as a dividend.

GRAIL, Inc. quarterly revenues are $43.6M, which are larger than Hypha Labs, Inc. quarterly revenues of --. GRAIL, Inc.'s net income of -$99.2M is lower than Hypha Labs, Inc.'s net income of -$521.6K. Notably, GRAIL, Inc.'s price-to-earnings ratio is -- while Hypha Labs, Inc.'s PE ratio is 4.88x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for GRAIL, Inc. is 13.17x versus 1.16x for Hypha Labs, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

Interpace Biosciences, Inc. has a net margin of -227.48% compared to GRAIL, Inc.'s net margin of 11.55%. GRAIL, Inc.'s return on equity of -16.95% beat Interpace Biosciences, Inc.'s return on equity of --.

GRAIL, Inc. has a consensus price target of $88.00, signalling upside risk potential of 66.79%. On the other hand Interpace Biosciences, Inc. has an analysts' consensus of -- which suggests that it could grow by 511.79%. Given that Interpace Biosciences, Inc. has higher upside potential than GRAIL, Inc., analysts believe Interpace Biosciences, Inc. is more attractive than GRAIL, Inc..

GRAIL, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Interpace Biosciences, Inc. has a beta of 1.170, suggesting its more volatile than the S&P 500 by 16.957%.

GRAIL, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Interpace Biosciences, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. GRAIL, Inc. pays -- of its earnings as a dividend. Interpace Biosciences, Inc. pays out -- of its earnings as a dividend.

GRAIL, Inc. quarterly revenues are $43.6M, which are larger than Interpace Biosciences, Inc. quarterly revenues of $8.8M. GRAIL, Inc.'s net income of -$99.2M is lower than Interpace Biosciences, Inc.'s net income of $1M. Notably, GRAIL, Inc.'s price-to-earnings ratio is -- while Interpace Biosciences, Inc.'s PE ratio is 6.68x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for GRAIL, Inc. is 13.17x versus 0.69x for Interpace Biosciences, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

Thermo Fisher Scientific, Inc. has a net margin of -227.48% compared to GRAIL, Inc.'s net margin of 16.21%. GRAIL, Inc.'s return on equity of -16.95% beat Thermo Fisher Scientific, Inc.'s return on equity of 13.23%.

GRAIL, Inc. has a consensus price target of $88.00, signalling upside risk potential of 66.79%. On the other hand Thermo Fisher Scientific, Inc. has an analysts' consensus of $666.46 which suggests that it could grow by 31.17%. Given that GRAIL, Inc. has higher upside potential than Thermo Fisher Scientific, Inc., analysts believe GRAIL, Inc. is more attractive than Thermo Fisher Scientific, Inc..

GRAIL, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Thermo Fisher Scientific, Inc. has a beta of 0.962, suggesting its less volatile than the S&P 500 by 3.778%.

GRAIL, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Thermo Fisher Scientific, Inc. offers a yield of 0.34% to investors and pays a quarterly dividend of $0.43 per share. GRAIL, Inc. pays -- of its earnings as a dividend. Thermo Fisher Scientific, Inc. pays out 9.7% of its earnings as a dividend. Thermo Fisher Scientific, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

GRAIL, Inc. quarterly revenues are $43.6M, which are smaller than Thermo Fisher Scientific, Inc. quarterly revenues of $12.2B. GRAIL, Inc.'s net income of -$99.2M is lower than Thermo Fisher Scientific, Inc.'s net income of $2B. Notably, GRAIL, Inc.'s price-to-earnings ratio is -- while Thermo Fisher Scientific, Inc.'s PE ratio is 28.64x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for GRAIL, Inc. is 13.17x versus 4.31x for Thermo Fisher Scientific, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

XWELL, Inc. has a net margin of -227.48% compared to GRAIL, Inc.'s net margin of -2.87%. GRAIL, Inc.'s return on equity of -16.95% beat XWELL, Inc.'s return on equity of -224.93%.

GRAIL, Inc. has a consensus price target of $88.00, signalling upside risk potential of 66.79%. On the other hand XWELL, Inc. has an analysts' consensus of -- which suggests that it could grow by 410.95%. Given that XWELL, Inc. has higher upside potential than GRAIL, Inc., analysts believe XWELL, Inc. is more attractive than GRAIL, Inc..

GRAIL, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison XWELL, Inc. has a beta of 0.866, suggesting its less volatile than the S&P 500 by 13.449%.

GRAIL, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. XWELL, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. GRAIL, Inc. pays -- of its earnings as a dividend. XWELL, Inc. pays out -- of its earnings as a dividend.

GRAIL, Inc. quarterly revenues are $43.6M, which are larger than XWELL, Inc. quarterly revenues of $7.3M. GRAIL, Inc.'s net income of -$99.2M is lower than XWELL, Inc.'s net income of -$211K. Notably, GRAIL, Inc.'s price-to-earnings ratio is -- while XWELL, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for GRAIL, Inc. is 13.17x versus 0.25x for XWELL, Inc.. Usually stocks with elevated PS ratios are considered overvalued.